Diós, Á.; Srinivasan, B.; Gyimesi, J.; Werkstetter, K.; Valenta, R.; Koletzko, S.; Korponay-Szabó, I.R.
Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease. Int. J. Mol. Sci. 2022, 23, 2498.
https://doi.org/10.3390/ijms23052498
AMA Style
Diós Á, Srinivasan B, Gyimesi J, Werkstetter K, Valenta R, Koletzko S, Korponay-Szabó IR.
Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease. International Journal of Molecular Sciences. 2022; 23(5):2498.
https://doi.org/10.3390/ijms23052498
Chicago/Turabian Style
Diós, Ádám, Bharani Srinivasan, Judit Gyimesi, Katharina Werkstetter, Rudolf Valenta, Sibylle Koletzko, and Ilma R. Korponay-Szabó.
2022. "Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease" International Journal of Molecular Sciences 23, no. 5: 2498.
https://doi.org/10.3390/ijms23052498
APA Style
Diós, Á., Srinivasan, B., Gyimesi, J., Werkstetter, K., Valenta, R., Koletzko, S., & Korponay-Szabó, I. R.
(2022). Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease. International Journal of Molecular Sciences, 23(5), 2498.
https://doi.org/10.3390/ijms23052498
